PD-1/PD-L1 Pathway Study on Septic Patients
NCT01161745 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39
Last updated 2010-07-14
Summary
The investigators want to identify that whether PD-1/PD-L1 pathway will change in human sepsis, and whether PD-1/PD-L1 pathway play an important role in sepsis induced immunosuppression.
Conditions
Sponsors & Collaborators
-
National Natural Science Foundation of China
collaborator OTHER_GOV -
Changhai Hospital
lead OTHER
Principal Investigators
-
Xiao-ming Deng, doctor · Changhai Hospital, the Second Military Medical University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2010-02-28
- Completion
- 2010-04-30
More Related Trials
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Dissecting How Peripheral Lymphocytes Are Lost During Sepsis
NCT03289312 ·Status: UNKNOWN
-
Study on the Role of Gamma Delta T Cells in Sepsis Immunosuppression and Its Molecular Mechanism
NCT02361970 ·Status: COMPLETED
-
Establishment of Early Diagnosis and Monitoring Model for Sepsis Patients
NCT04974411 ·Status: UNKNOWN
-
The Th9/IL-9 and Early Enteral Nutrition in Sepsis
NCT03791866 ·Status: UNKNOWN ·Phase: NA
-
The Th17/Treg Cells and IL-23/IL-17 Axis and Early Enteral Nutrition in Sepsis
NCT03385850 ·Status: COMPLETED ·Phase: NA
-
Early Identification and Effective Management of Pediatric Sepsis
NCT03996720 ·Status: COMPLETED
-
Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
NCT02887274 ·Status: UNKNOWN
-
Immune Function Monitoring and Immunotherapy in Sepsis
NCT04903405 ·Status: UNKNOWN
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Alterations of Immunologic Mediators During Severe Sepsis
NCT00484146 ·Status: TERMINATED
-
Treatment of IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.
NCT04850443 ·Status: WITHDRAWN
-
Efficacy and Safety Study of CA330 Hemoadsorption Device on IL-6 Removal in Septic Patients
NCT03847961 ·Status: UNKNOWN ·Phase: NA
-
Comparison the Value of Several Biomarkers of Sepsis
NCT01388725 ·Status: COMPLETED
-
Role of Inflammatory Markers in Sepsis
NCT06111963 ·Status: COMPLETED
-
Dendritic Cells-Derived Exosomes in Human Sepsis
NCT02957279 ·Status: UNKNOWN
-
Genomics in Infection and Sepsis to Predict Organ Dysfunction and Outcomes in Sepsis
NCT04199962 ·Status: UNKNOWN
-
Biomarkers in Exhaled Breath Condensates of Septic Patients to Predict Development of Multi-organ Dysfunction Syndrome
NCT01503684 ·Status: UNKNOWN
-
Expression of TIM-3 on Lymphocytes in Sepsis
NCT02319876 ·Status: UNKNOWN
-
Association Between cd163 Gene Polymorphisms and Sepsis Among Chinese Han Population
NCT01504243 ·Status: UNKNOWN
-
Procalcitonin to Shorten Antibiotics Duration in ICU Patients
NCT01379547 ·Status: UNKNOWN ·Phase: PHASE3
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT01535534 ·Status: UNKNOWN
-
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001 ·Status: ENROLLING_BY_INVITATION
-
TREM-1 Gene Polymorphisms
NCT01490424 ·Status: COMPLETED